BET INHIBITION BLOCKS TUMOR PROGRESSION AND PROMOTES DIFFERENTIATION IN NEUROBLASTOMA

BACKGROUND: MYCN amplification is a key molecular hallmark of high-risk neuroblastoma. Previously considered an “undruggable” target, MYCN transcription can be disrupted by inhibiting the bromodomain and extraterminal (BET) domain family of proteins that epigenetically regulates MYCN transcription....

Full description

Saved in:
Bibliographic Details
Published in:Surgery
Main Authors: Lee, Sora, Rellinger, Eric J., Kim, Kwang Woon, Craig, Brian T., Romain, Carmelle V., Qiao, Jingbo, Chung, Dai H.
Format: Artigo
Language:Inglês
Published: 2015
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4536146/
https://ncbi.nlm.nih.gov/pubmed/26067464
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.surg.2015.04.017
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items